2006
DOI: 10.1016/j.jbusvent.2005.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Alliance type, alliance experience and alliance management capability in high-technology ventures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

22
525
2
13

Year Published

2008
2008
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 557 publications
(577 citation statements)
references
References 79 publications
22
525
2
13
Order By: Relevance
“…Taking into account the existing body of knowledge on the impact of a firm's alliance portfolio on its characteristics and performance (Rothaermel and Deeds, 2006;Lavie, 2007), large companies more and more often were managing their alliance portfolios incorporating partners, and using partners' resources as network resources. However as previous research showed (Golonka, 2014;Golonka and Latusek, 2016), small and medium firms did not manage their alliance portfolios; those portfolios consisted of many random and independent relationships.…”
Section: Jmbace 73mentioning
confidence: 99%
“…Taking into account the existing body of knowledge on the impact of a firm's alliance portfolio on its characteristics and performance (Rothaermel and Deeds, 2006;Lavie, 2007), large companies more and more often were managing their alliance portfolios incorporating partners, and using partners' resources as network resources. However as previous research showed (Golonka, 2014;Golonka and Latusek, 2016), small and medium firms did not manage their alliance portfolios; those portfolios consisted of many random and independent relationships.…”
Section: Jmbace 73mentioning
confidence: 99%
“…Much of the previous studies on inter-firm collaboration implicitly locates biotech SMEs at the upstream pole of the established firms (for example, pharmaceutical or agricultural biotechnology) along industry value chains [10]- [12]. On the other hand, many biotech SMEs collaborate with universities or public research institutions in what are referred to as upstream partnerships [10], [13]- [16].…”
Section: Hypothesismentioning
confidence: 99%
“…If so, then the marginal effect of additional R&D partnerships decreases, and perhaps becomes negative, with an increase in the size of a portfolio. Firms will enter the most promising partnerships first and so the amount of relevant information drawn from additional partners, and the concomitant potential for uncertainty reduction, should gradually decrease (Rothaermel & Deeds, 2006). Moreover, increasing the size of a portfolio increases burdens on their management and monitoring (Deeds & Hill, 1996).…”
Section: Portfolio Sizementioning
confidence: 99%
“…Recent studies argue that R&D partnership portfolios, more than individual partnerships alone, represent key knowledge-gathering conduits that allow firms to leverage informational complementarities across their various R&D projects (Faems, van Looy, & Debackere, 2005;George, Zahra, Wheatley, & Khan, 2001;Munson & Spivey, 2006). Consistent with this view, several studies have shown empirical associations between R&D partnership portfolios and innovation (Powell et al, 1999;Rothaermel & Deeds, 2006;Soh, 2003;Stuart, 2000;Wuyts, Dutta, & Stremersch, 2004), while others have suggested a link between technological uncertainty and firms' proclivity to engage in multiple simultaneous R&D partnerships (Hagedoorn, 1993;Powell, Koput, & Smith-Doerr, 1996;Rosenkopf & Schilling, 2008).…”
Section: Introductionmentioning
confidence: 98%